Clinical Trials on Sexually Transmitted Diseases

Total 388201 results

ViiV Healthcare

Completed

Study to Evaluate the Effect of GSK3640254 on the Pharmacokinetics of Tenofovir Alafenamide/Emtricitabine

HIV Infections

United States
Simon Fraser University
Massachusetts General Hospital; Mbarara University of Science and Technology

Completed

Getting to Zero: Safer Conception Programming Among HIV Sero-different Couples in Uganda (G2Z)

HIV Infections

Uganda
Kirby Institute

Completed

Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults. (ENCORE1)

HIV Infections

Australia
Yu-Jay Corp.

Completed

Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) in Combo Tablet for Patients Receiving Atripla With Viral Suppression in Taiwan

HIV Infections

Taiwan
Fundacion SEIMC-GESIDA
Janssen-Cilag, S.A.

Completed

Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice (CoDAR)

HIV Infections

Spain
Germans Trias i Pujol Hospital

Completed

Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine

HIV Infections

Spain
Rob Gruters
Hospital Clinic of Barcelona; Germans Trias i Pujol Hospital; Universitair Ziekenhuis... and other collaborators

Terminated

iHIVARNA Clinical Trial in HIV Infected Individuals (iHIVARNA-01)

HIV Infections

Netherlands, Spain, Belgium
National Cancer Institute (NCI)

Completed

Natural History Study of HIV Acquired in Infancy or Childhood

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection

HIV Infections

United States
ViiV Healthcare
GlaxoSmithKline; Pharmaceutical Product Development (PPD), Inc

Completed

To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers

HIV Infections

United States
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment

HIV Infections

Spain
University of Illinois at Chicago
National Institute on Drug Abuse (NIDA)

Completed

Seek, Test, Treat, Retain: An Integrated Jail-Prison-Community Model for Illinois

HIV Infections

United States
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Understanding the Increased Risk of Cardiovascular Disease in People With HIV

HIV Infections
ViiV Healthcare

Completed

A Study to Compare the Relative Bioavailability of Two Different Formulations of GSK3640254

HIV Infections

United Kingdom
Imperial College London
Biomedical Research and Training Institute

Completed

Scientific Evaluation of Peer Education and STD Treatment to Reduce the Spread of HIV in Zimbabwe

HIV Infections

Zimbabwe
University of California, San Diego
Merck Sharp & Dohme LLC

Completed

Cerebrospinal Fluid (CSF) Raltegravir Substudy

HIV Infections
Merck Sharp & Dohme LLC

Completed

A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)

HIV Infections
National Institute of Allergy and Infectious Diseases...

Unknown

Multicenter AIDS Cohort Study (MACS)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Unknown

Women's Interagency HIV Study (WIHS)

HIV Infections

United States
Medical College of Wisconsin
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations

HIV Infections

United States
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); Ontario HIV Treatment Network; CIHR Canadian HIV Trials Network

Completed

Combination Vaccination Before HIV Treatment Interruption

HIV Infections

Canada
University of Cape Town
Desmond Tutu HIV Centre; Wits Reproductive Health and HIV Institute

Terminated

Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers (Darifi)

HIV Infections

South Africa
ViiV Healthcare
GlaxoSmithKline

Completed

Prospective Non-Interventional Observational Study of Use of TRIUMEQ and Corresponding Monitoring Measures in Clinical Practice in Germany (TRIUMPH)

HIV Infections

Germany
ViiV Healthcare
Pfizer

Terminated

Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay

HIV Infections

United States, Canada
Azienda Socio Sanitaria Territoriale degli Spedali...

Completed

Impact of Different Integrase Inhibitor Based Regimen on Immune Activation Among HIV naïve Patient (INTATTI) (INTATTI)

HIV Infections

Italy
San Francisco State University
Johns Hopkins University; University of Colorado, Denver; University of California...

Unknown

A Randomized Trial to Prevent HIV Among Gay Couples

HIV Infections

United States
Johns Hopkins University
University of California, San Francisco

Completed

Improving Provider Counseling Interventions in HIV Practice

HIV Infections

United States
GlaxoSmithKline

Completed

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

HIV Infections
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression

HIV Infections

United States
Boehringer Ingelheim

Withdrawn

Surveillance Cohort Long-term Toxicity Antiretrovirals in HIV-infected Patients Enrolled in TPV Cohort

HIV Infections
National Institutes of Health Clinical Center (CC)

Terminated

Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy

HIV Infections

United States
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir (VIKING-4)

HIV Infections

United States
ViiV Healthcare
Senopsys, LLC

Completed

Taste Properties of HIV Inhibitor

HIV Infections

United States
Medicines Development for Global Health
Imperial College London; Phillip T. and Susan M. Ragon Foundation

Terminated

A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People

HIV Infections

United Kingdom
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy

HIV Infections

Malawi, South Africa, India, Tanzania, Thailand
Education Development Center, Inc.

Completed

Reducing HIV Risks in African American Teens

HIV Infections

United States
Hospital Clinic of Barcelona
Fundacion Clinic per a la Recerca Biomedica; Brighton and Sussex University... and other collaborators

Unknown

Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE) (EMERGE)

HIV Infections

Spain, Belgium, Croatia, Portugal, United Kingdom
Community Research Initiative of New England
The Campbell Foundation

Completed

FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment

HIV Infections

United States
International Partnership for Microbicides, Inc.

Completed

Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring

HIV Infections

Belgium
International Partnership for Microbicides, Inc.

Completed

Assessing the Safety of Dapivirine Gel and Film Formulations

HIV Infections

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Telephone Support to Improve Adherence to Anti-HIV Medications

HIV Infections

United States
Community Research Initiative of New England

Completed

BRAVO: Background Regimen of Raltegravir on Virologic Outcome (BRAVO)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Study of Vaccination Schedule of Experimental HIV Vaccines

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Daclizumab to Treat HIV-Infected Patients

HIV Infections

United States
University of Colorado, Denver

Completed

Effect of Antacids on the Pharmacokinetics of Raltegravir

HIV Infections

United States
University of Pittsburgh
National Institute of Nursing Research (NINR)

Completed

Managing Medications (MM2)

HIV Infections

United States
Therapeutic Concepts
Abbott; Tibotec, Inc; BluKyne

Completed

A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects (KALYINTE)

HIV Infections

United States
St. Jude Children's Research Hospital

Terminated

Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults

HIV Infections

United States
Merck Sharp & Dohme LLC

Completed

A Pharmacokinetic Study to Evaluate the Effect of Antacids on Raltegravir (MK-0518) in HIV-Infected Participants (MK-0518-247)

HIV Infections
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)

HIV Infections

Clinical Trials on Sexually Transmitted Diseases

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations